Clinical risk stratification of paediatric renal transplant recipients using C1q and C3d fixing of de novo donor-specific antibodies

[1] Rees L(2014)HLA sensitisation: can it be prevented? Pediatr Nephrol 30 577-587

[2] Kim JJ(2014)Kidney transplantation in children N Engl J Med 371 549-558

[3] Dharnidharka VR(2014)Long-term outcomes in paediatric solid organ transplantation Clinics 69 28-38

[4] Fiorina P(2014)The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients Am J Transplant 14 2350-2358

[5] Harmon WE(2013)Complement-binding anti-HLA antibodies and kidney-allograft survival N Engl J Med 369 1215-1226

[6] Kim JJ(2014)Detection of C3d−binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss J Am Soc Nephrol 26 457-467

[7] Marks SD(2013)Nlme: linear and nonlinear mixed effects models R Package Version 3 1-131

[8] Kim JJ(2005)Mycophenolate Mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the “creeping creatinine” study Transplantation 79 466-475

[9] Balasubramanian R(2009)Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection Pediatr Transplant 13 475-481

[10] Michaelides G(2015)The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection Trends Mol Med 21 319-329

[1] Rees L(2014)HLA sensitisation: can it be prevented? Pediatr Nephrol 30 577-587

[2] Kim JJ(2014)Kidney transplantation in children N Engl J Med 371 549-558

[3] Dharnidharka VR(2014)Long-term outcomes in paediatric solid organ transplantation Clinics 69 28-38

[4] Fiorina P(2014)The clinical spectrum of de novo donor-specific antibodies in pediatric renal transplant recipients Am J Transplant 14 2350-2358

[5] Harmon WE(2013)Complement-binding anti-HLA antibodies and kidney-allograft survival N Engl J Med 369 1215-1226

[6] Kim JJ(2014)Detection of C3d−binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss J Am Soc Nephrol 26 457-467

[7] Marks SD(2013)Nlme: linear and nonlinear mixed effects models R Package Version 3 1-131

[8] Kim JJ(2005)Mycophenolate Mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the “creeping creatinine” study Transplantation 79 466-475

[9] Balasubramanian R(2009)Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection Pediatr Transplant 13 475-481

[10] Michaelides G(2015)The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection Trends Mol Med 21 319-329